Phoenix, Arizona 85050


Purpose:

This study will evaluate the intraocular pressure-lowering effect and safety of Bimatoprost SR compared with selective laser trabeculoplasty in patients with open-angle glaucoma or ocular hypertension who are not adequately managed with topical IOP-lowering medication.


Criteria:

Inclusion Criteria: - Diagnosis of either Open-Angle Glaucoma or Ocular Hypertension in each eye that require IOP lowering treatment. Exclusion Criteria: - Eye surgery (including cataract surgery) and or eye laser surgery within the past 6 months. - Enrollment in other studies using Bimatoprost SR.


NCT ID:

NCT02507687


Primary Contact:

Study Director
Marina Bejanian
Allergan

Clinical Trial Registry Team
Phone: 877-277-8566
Email: IR-CTRegistration@allergan.com


Backup Contact:

N/A


Location Contact:

Phoenix, Arizona 85050
United States

Study Coordinator
Phone: 480-999-5458

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.